Cargando…

Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology

ActRIIB (activin receptor type-2B) is an activin receptor subtype constitutively expressed in the whole body, playing a role in cellular proliferation, differentiation, and metabolism. For its various physiological activities, ActRIIB interacts with activin and multiple other ligands including myost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, Kotaro, Kanematsu-Yamaki, Yoko, Kamada, Yusuke, Oka, Masahiro, Ohnishi, Toshiyuki, Miwa, Masanori, Asami, Taiji, Inooka, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614685/ https://www.ncbi.nlm.nih.gov/pubmed/28955765 http://dx.doi.org/10.1016/j.bbrep.2017.06.001

Ejemplares similares

Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition
por: Goncalves, Marcus D., et al.
Publicado: (2010)

Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
por: Queiroz, Andre Lima, et al.
Publicado: (2022)

Preliminary Investigation into a Potential Role for Myostatin and Its Receptor (ActRIIB) in Lean and Obese Horses and Ponies
por: Morrison, Philippa K., et al.
Publicado: (2014)

Adult-Specific Systemic Over-Expression Reveals Novel In Vivo Effects of the Soluble Forms of ActRIIA, ActRIIB and BMPRII
por: Yamawaki, Kengo, et al.
Publicado: (2013)

Electrical impedance myography as a biomarker of myostatin inhibition with ActRIIB-mFc: a study in wild-type mice
por: Nagy, Janice A, et al.
Publicado: (2018)

BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways
por: Wen, Jialing, et al.
Publicado: (2019)

Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
por: Busquets, Sílvia, et al.
Publicado: (2011)

Selection of silk-binding peptides by phage display
por: Nomura, Yoko, et al.
Publicado: (2011)

A novel LRP1-binding peptide L57 that crosses the blood brain barrier
por: Sakamoto, Kotaro, et al.
Publicado: (2017)

Phage Display Informatics
por: Huang, Jian, et al.
Publicado: (2013)

Antibody Phage Display
por: Aitken, Rob
Publicado: (2008)

Dichotomy in FcγRIIB deficiency and autoimmune-prone SLAM haplotype clarifies the roles of the Fc receptor in development of autoantibodies and glomerulonephritis
por: Kanari, Yasuyoshi, et al.
Publicado: (2014)

Eliminating helper phage from phage display
por: Chasteen, L., et al.
Publicado: (2006)

The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs
por: Krumpe, Lauren R.H., et al.
Publicado: (2006)

Landscape Phage: Evolution from Phage Display to Nanobiotechnology
por: Petrenko, Valery A.
Publicado: (2018)

Identification of a peptide antagonist of the FGF1–FGFR1 signaling axis by phage display selection
por: Lipok, Magdalena, et al.
Publicado: (2019)

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016)

The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019)

Trinucleotide cassettes increase diversity of T7 phage-displayed peptide library
por: Krumpe, Lauren RH, et al.
Publicado: (2007)

Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2022)

Expanding the Versatility of Phage Display I: Efficient Display of Peptide-Tags on Protein VII of the Filamentous Phage
por: Løset, Geir Åge, et al.
Publicado: (2011)

Phage display mediated immuno-PCR
por: Guo, Yong-Chao, et al.
Publicado: (2006)

Phage Display Libraries Identify T Cells
Publicado: (2004)

Basics of Antibody Phage Display Technology
por: Ledsgaard, Line, et al.
Publicado: (2018)

Bioinformatics Resources and Tools for Phage Display
por: Huang, Jian, et al.
Publicado: (2011)

Phage Display to Augment Biomaterial Function
por: Davidson, Thomas A., et al.
Publicado: (2020)

Phage display in the study of infectious diseases
por: Mullen, Lisa M., et al.
Publicado: (2006)

Phage display for targeting PCSK9
por: Ferri, Nicola
Publicado: (2021)

Discovery of Antivirals Using Phage Display
por: Sokullu, Esen, et al.
Publicado: (2021)

Editorial: Phage display: Technique and applications
por: Huang, Jian, et al.
Publicado: (2022)

Transmembrane domain dependent inhibitory function of FcγRIIB
por: Wang, Junyi, et al.
Publicado: (2018)

FcγRIIB is a T cell checkpoint in antitumor immunity
por: Farley, Clara R., et al.
Publicado: (2021)

Role of lipid nanodomains for inhibitory FcγRIIb function
por: Spiegel, Franziska, et al.
Publicado: (2023)

Integration of phage and yeast display platforms: A reliable and cost effective approach for binning of peptides as displayed on-phage
por: Pandya, Priyanka, et al.
Publicado: (2020)

Creation of mouse TNFR2-selective agonistic TNF mutants using a phage display technique
por: Ando, Daisuke, et al.
Publicado: (2016)

Protocol for design, construction, and selection of genome phage (gPhage) display libraries
por: Rodriguez Carnero, Luis Antonio, et al.
Publicado: (2021)

Distinct cell-specific control of autoimmunity and infection by FcγRIIb
por: Brownlie, Rebecca J., et al.
Publicado: (2008)

Genetic Modifiers of Systemic Lupus Erythematosus in FcγRIIB(−/−) Mice
por: Bolland, Silvia, et al.
Publicado: (2002)

High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis
por: Magnusson, Sofia E, et al.
Publicado: (2007)

Lupus-like Disease in FcγRIIB(−/−) Mice Induces Osteopenia
por: Visitchanakun, Peerapat, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_34aud4hbirntsbao4c0fhlf524